GBIO
Generation Bio Co

833
Mkt Cap
$37.6M
Volume
1,269.00
52W High
$8.66
52W Low
$3.00
PE Ratio
-0.60
GBIO Fundamentals
Price
$5.57
Prev Close
$5.58
Open
$5.57
50D MA
$5.43
Beta
2.06
Avg. Volume
61,845.77
EPS (Annual)
-$19.76
P/B
0.74
Rev/Employee
$172,973.91
Loading...
Loading...
News
all
press releases
Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs
Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (Satellos or the Company), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today...
Business Wire·3h ago
News Placeholder
More News
News Placeholder
Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages DHIL, GBIO, CTGO Shareholders to Contact the Firm to Discuss Their...
PR Newswire·6d ago
News Placeholder
Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages CTGO, GBIO, CDE Shareholders to Contact the Firm to Discuss Their...
PR Newswire·16d ago
News Placeholder
Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages QIPT, FITB, GBIO, APLT Shareholders to Contact the Firm to...
PR Newswire·1mo ago
News Placeholder
Compass Pathways Appoints Dr. Jeffrey Jonas to Board of Directors
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the appointment of Dr. Jeffrey...
Business Wire·3mo ago
News Placeholder
Generation Bio Stock Surged 31% Pre-Market Today – What’s Going On?
Generation Bio on Tuesday said that it is evaluating strategic alternatives to maximize the value of its assets for shareholders and implementing a strategic restructuring expected to result in a 90% reduction in workforce.
Stocktwits·6mo ago
News Placeholder
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
Generation Bio (GBIO) delivered earnings and revenue surprises of -11.43% and -51.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6mo ago
News Placeholder
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Beats Revenue Estimates
Orchestra BioMed Holdings, Inc. (OBIO) delivered earnings and revenue surprises of +1.96% and +16.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·6mo ago
News Placeholder
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
chainwire·9mo ago
<
...
1
>

Latest GBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.